Clinical Study

A Randomized Double-Blind Phase 3 Trial Comparing Vintafolide (Ec145) And Pegylated Liposomal Doxorubicin (Pld/Doxil?/Caelyx?) In Combination Versus P

Posted Date: May 15, 2019

  • Investigator: Eric Eisenhauer
  • Specialties:
  • Type of Study: Drug

You are being asked to take part in a research study of an investigational drug called Vintafolide. Vintafolide was previously identified as EC145. Investigational means that the study drug is currently being tested and is not approved for sale in the United States by the Food and Drug Administrat

Criteria:

You Are Being Asked To Take Part Because You Are 18 Years Of Age Or Older And Have ?Platinum-Resista

Keywords:

Ec145, Gynecologic Oncology, Ovarian Cancer, Platinum Resistant, Vintafolide

For More Information:

Michael Blakeman
513-584-5044
michael/blakeman@uc.edu


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.